NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/12/2022
Back to search
Official data from USPTO
DIRECT2PATIENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
07/12/2022
Trademark type
Combined
Nice classes
39
Filing date
03/12/2021
Registration date
07/12/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/12/2022
Last transaction
07/12/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
03/24/2021
First use in commerce
03/24/2021
Drawing code
3
Owner type
65
Owner location
BAGSVAERD, DK
Examiner
PETTICAN, NATHANIEL
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "DIRECT" and "PATIENT" on either side of the number "2" in a circle located in the center of the two words "DIRECT" and "PATIENT".
Holders and representatives
Holders
NOVOZYMES A/S
Physicians Exclusive LLC
Representatives
Ashley Rovner-Watson AMIN TALATI WASSERMAN, LLP
Technical classification
Nice Classes
Class 39
Vienna Codes
No Vienna codes available.
Goods and services
Class 39
Warehousing servicesstoragedistributionpick-uppackingshipping of dietary and nutritional supplements
Publications
History of USPTO decisions and trademark events.
30 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
07/12/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/27/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/27/2022
ALIE
ASSIGNED TO LIE
05/27/2022
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
05/26/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/25/2022
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/25/2022
IUAA
USE AMENDMENT ACCEPTED
05/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/18/2022
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/18/2022
IUAF
USE AMENDMENT FILED
05/18/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/17/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/17/2022
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/17/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/16/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/17/2021
GNFR
FINAL REFUSAL E-MAILED
11/17/2021
CNFR
FINAL REFUSAL WRITTEN
11/17/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/14/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/14/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/14/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/06/2021
GNRT
NON-FINAL ACTION E-MAILED
08/06/2021
CNRT
NON-FINAL ACTION WRITTEN
08/06/2021
DOCK
ASSIGNED TO EXAMINER
08/05/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/15/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/13/2021
NWAP
NEW APPLICATION ENTERED
03/16/2021
Continuous trademark protection
Get notified about every new filing that threatens DIRECT2PATIENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.